We find the clinical and financial blindspots that kill Seed/Series A MedTech rounds. Get a video diagnostic backed by proprietary, verifiable data and a proven remediation plan in 72 hours.
Apply NowWhen investors pass on a MedTech startup, it's rarely because the science is bad. It is because documents look inconsistent and the approach sounds unfundable. They say "keep us updated" and pass.
Clinical assumptions and trial timelines that don't match the financial model's burn rate.
A synchronized milestone-to-cash roadmap proving you reach the next value inflection point before running out of money.
Treating FDA (510k/De Novo) or MDR pathways as simple, best-case scenarios with no buffer.
A de-risked regulatory timeline accounting for clinical adoption based on industry benchmarks, indication-specific recruitment needs and clinical data bottlenecks.
Pitching a top-down "$10 Billion TAM" based on total disease prevalence.
A bottom-up economic analysis showing reachable patient population, reimbursement codes and growth rates.
A system that connects data, industry intelligence and execution frameworks for MedTech companies.
Fully GDPR compliant. Hosted on localized servers in Frankfurt, Germany. We utilize a Zero-Retention AI Engine, which means that your data is never used to train external models.
Actionable answers for MedTech founders.
A 30-minute video recording with a detailed review of your documents and financial model from a former institutional analyst.
No scheduling friction. You'll get the video directly in your inbox within 72 hours.
A visual timeline cross-referencing your clinical and regulatory timeline directly against the burn rate in your Excel model.
We align your capital requirements with your clinical, regulatory and growth assumptions, before and after your key value inflection points.
A step-by-step, prioritized action list detailing exactly what to rewrite, remove, or defend within your Data Room.
Instead of guessing how to fix the gaps, you get a tiered checklist of things to improve before you open your data room.
After you get time to digest the video tear-down and the remediation protocol, we get on a live 45-minute call.
This is a tactical Q&A where we clear any remaining open points, role-play the pushback you will get from investors and pressure-test your answers.
When you submit your documents, we guarantee we will identify at least one major flaw in your clinical timeline, financial model, or regulatory strategy.
If we conclude your company is bulletproof, we'll let you know within 24 hours. You'll get the ultimate validation and it costs you nothing.
Legacy corporate management is not made for startups. Consultants charge €15,000 for a six-week process only to hand you a 30-page PDF that neither you nor your investors have time to read. They have simply never done it.
At Argomedix, we replaced legacy consulting decks with a structured stress test. By leveraging a custom Intelligence Stack, we compress a six-week review into a 72-hour audit, followed by a custom strategic synthesis.
“I founded Argomedix because the MedTech ecosystem needs more builders. Every day, great science dies because founders are drowned in strategy but starve for execution. As a bioengineer, startup operator and investor across the US and Europe, I've seen what companies need to get investors and acquirers to write the check.”
Don't let fixable blindspots cost you your round.
Idea-stage founders without preliminary data or researchers who have not yet started a company
Pharmaceutical companies, service-led firms and generic SaaS
Founders looking for better storytelling and pretty slides
Seed & Series A MedTech companies with scientific/technical validation
Companies closing an investment round within the next 6 months
Founders looking to fix the math and clinical logic behind the company